Fig 1.
The diagram for hepatitis B serosurvey in a cohort of medical students.
Table 1.
Characteristics of all medical students and those with post-booster HB vaccination.
Fig 2.
Percentage of individuals with pre-existing anti-HBs <10 mIU/ml who demonstrated protective anti-HBs status (>10 mIU/ml) post-booster.
Fig 3.
Anti-HBs levels before and after HB vaccine booster.
Individuals with insufficient protective anti-HBs (<10 mIU/ml) classified into 3 groups (<1 mIU/ml, 1-<3 mIU/ml, and 3–10 mIU/ml) and had received a HB booster. Anti-HBs were evaluated 6 weeks post-booster.
Fig 4.
Anti-HBs levels post-booster among individuals with varying pre-existing anti-HBs.
(A) Individuals were grouped based on their pre-existing anti-HBs (<1 mIU/ml, 1-<3 mIU/ml and 3-<10 mIU/ml shown on the X-axis). Percentage of individuals with post-booster anti-HBs (Y-axis) of <10 mIU/ml (white), 10-<100 mIU/ml (light blue), and >100 mIU/ml (dark blue). (B) Geometric mean titers of anti-HBs post-booster among individuals with different pre-existing anti-HBs.